Silberman David - Insider Non-Derivative Transactions at ORAMED PHARMACEUTICALS INC. (ORMP) - (SEC)

Updated on December 12, 2024.

According to recent SEC insider information filed on Jan 4, 2024, Silberman David's relationship to ORAMED PHARMACEUTICALS INC. (ORMP) is Officer (Chief Financial Officer), and currently has 366,500 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other ORMP insiders.

Data Source: SEC.
Silberman David - Insider Non-Derivative Transactions of ORMP Common Stock
Silberman David - Insider Non-Derivative Transactions at ORMP
Items per page:
0 of 0
Date Transaction No. of Shares Price Per Share Shares Owned After Transactions
Jan 5, 2024 Acquisition -- (Common Stock) 136500 0 366500
May 27, 2023 Acquisition -- (Common Stock) 24500 0 230000
Apr 18, 2023 Acquisition -- (Common Stock) 97500 0 205500